Last reviewed · How we verify

NCT06290492

Clinical Efficacy and Mechanism of High Definition tDCS Based on dmPFC in the Intervention of Chronic Insomnia

Completed NA Last updated 6 March 2025
What this trial tests

NA trial testing transcranial direct current stimulation in Chronic Insomnia in 45 participants. Completed in 1 November 2024.

Timeline
1 May 2023
Primary endpoint
30 June 2024
1 November 2024

Quick facts

Lead sponsorWANG KAI
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment45
Start date1 May 2023
Primary completion30 June 2024
Estimated completion1 November 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

WANG KAI

Who can join

Adults 15 to 65, any sex, with Chronic Insomnia or Transcranial Direct Current Stimulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the intervention effect of transcranial direct current stimulation (tDCS) on subjective and objective insomnia symptoms and daytime function of chronic insomnia patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of high-definition transcranial direct current stimulation for the treatment of chronic insomnia: a randomized, double-blind, controlled trial.
    Li J, Li A, Jiao J, Hu K, et al · · 2025 · cited 2× · PMID 40695876 · DOI 10.1038/s41598-025-09304-4

Verify or expand the search:

Other trials of transcranial direct current stimulation

Trials testing the same drug.

Other recruiting trials for Chronic Insomnia

Currently open trials in the same condition.

Other WANG KAI trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06290492.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing